Methylene Blue for Bipolar Disorder: From 1980s Trials to a Modern RCT
Methylene blue has been tested in bipolar disorder in controlled trials since the 1980s, including a 2017 randomized crossover study and a 2024 neuroimaging RCT. The serotonin syndrome risk is central to reading any of it.











